Clinical trial
Valproic Acid With Temozolomide and Radiation Therapy to Treat Brain Tumors
NCT00302159 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00302159 |
|---|---|
| Title | Valproic Acid With Temozolomide and Radiation Therapy to Treat Brain Tumors |
| Official title | A Phase II Clinical Trial of the Histone Deacetylase Inhibitor Valproic Acid in Combination With Temodar and Radiation Therapy in Patients With High Grade Gliomas: Multi-Institutional Trial |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | High Grade Gliomas, Brain Tumors |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | adjuvant therapy, Temozolomide, Valproic Acid, Radiation therapy |
| Enrollment | 43 |
| Start date | Mar 1, 2006 |
| Primary completion | Jun 1, 2013 |
| Completion | Nov 1, 2014 |
| First posted | Mar 13, 2006 |
| Last update posted | Aug 18, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: